T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Zymeworks
ZYME
$1.83B
| $94K | ﹤0.01% |
+10,822
| New | +$96.9K |
|
|
ASXC
2702
DELISTED
Asensus Surgical, Inc.
ASXC
| $94K | ﹤0.01% |
185,500
| – | – |
|
|
CHMI
2703
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $93K | ﹤0.01% |
19,062
| – | – |
|
|
CTLP
2704
DELISTED
Cantaloupe
CTLP
| $93K | ﹤0.01% |
11,662
+593
| +5% | +$3.84K |
|
|
WOW
2705
DELISTED
WideOpenWest
WOW
| $93K | ﹤0.01% |
10,970
+794
| +8% | +$7.17K |
|
2706
Alpha Pro Tech
APT
$55.2M
| $92K | ﹤0.01% |
22,900
| – | – |
|
2707
Altimmune
ALT
$558M
| $91K | ﹤0.01% |
25,647
+5,847
| +30% | +$26.3K |
|
2708
Expensify
EXFY
$202M
| $90K | ﹤0.01% |
+11,201
| New | +$82.2K |
|
2709
QuinStreet
QNST
$1.19B
| $90K | ﹤0.01% |
+10,192
| New | +$103K |
|
2710
Stereotaxis
STXS
$137M
| $90K | ﹤0.01% |
58,400
| – | – |
|
|
ME
2711
DELISTED
23andMe Holding Co
ME
| $90K | ﹤0.01% |
2,559
+157
| +7% | +$6.25K |
|
|
IAUX
2712
i-80 Gold Corp
IAUX
$1.45B
| $89K | ﹤0.01% |
+39,176
| New | +$92.3K |
|
2713
TAL Education Group
TAL
$6.35B
| $89K | ﹤0.01% |
14,900
-9,200
| -38% | -$55.1K |
|
2714
Aspen Aerogels
ASPN
$505M
| $85K | ﹤0.01% |
+10,688
| New | +$74.4K |
|
2715
Quantum-Si Incorporated
QSI
$189M
| $85K | ﹤0.01% |
47,381
+1,030
| +2% | +$1.61K |
|
|
KG
2716
Kestrel Group
KG
$61.8M
| $84K | ﹤0.01% |
1,988
+923
| +87% | +$39.4K |
|
2717
MaxCyte
MXCT
$152M
| $84K | ﹤0.01% |
18,123
+1,494
| +9% | +$6.87K |
|
|
ENZ
2718
DELISTED
Enzo Biochem, Inc.
ENZ
| $83K | ﹤0.01% |
44,800
| – | – |
|
|
SUNW
2719
DELISTED
Sunworks, Inc.
SUNW
| $83K | ﹤0.01% |
73,400
| – | – |
|
2720
Custom Truck One Source
CTOS
$2.41B
| $82K | ﹤0.01% |
12,101
+330
| +3% | +$2.17K |
|
2721
US Global Investors
GROW
$38.7M
| $82K | ﹤0.01% |
26,700
| – | – |
|
2722
Solid Power
SLDP
$543M
| $82K | ﹤0.01% |
31,959
+6,564
| +26% | +$15.1K |
|
|
ASTR
2723
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $82K | ﹤0.01% |
14,820
-1,642
| -10% | -$9.39K |
|
2724
Ardagh Metal Packaging
AMBP
$3.13B
| $81K | ﹤0.01% |
21,453
-3,058,164
| -99% | -$11.3M |
|
2725
PLAYSTUDIOS Inc
MYPS
$67.3M
| $81K | ﹤0.01% |
16,456
+2,291
| +16% | +$10K |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.